dr. andrew zelenetz on the treatment of hematologic malignancies
Published 11 years ago • 170 plays • Length 2:30Download video MP4
Download video MP3
Similar videos
-
9:05
understanding car t-cell therapy for lymphoma with andrew zelenetz, md, phd
-
1:58
dr. zelenetz on current treatment options for mcl
-
47:04
current approaches and emerging therapies in the treatment of malignant lymphoma professor andreas e
-
1:13
dr. andrew zelenetz on the impact of rituximab in lymphoma
-
1:22:38
how i treat hematologic malignancies series: “follicular lymphoma”
-
1:49
dr. andrew zelenetz on targeted therapies for diffuse large b-cell lymphoma
-
1:24
dr. andrew zelenetz discusses treatment options for dlbcl
-
4:21
lymphoma: diagnosis, stages, treatment and life afterwards
-
26:52
ep 95: low dose naltrexone (ldn) - what when why how
-
5:59
cutaneous lymphoma treatment series - video 4: systemic therapies
-
2:09
dr. andrew zelenetz previews the 2012 american society of hematology annual meeting
-
1:33
dr. zelenetz on treatment for patients with cll who fail on ibrutinib or idelalisib
-
2:33
ash highlights in cll and lymphoma by dr andrew zelenetz
-
1:31
dr. zelenetz on progress made in mcl treatment
-
2:05
dr. zelenetz on potential of acalabrutinib and bgb-3111 in cll
-
1:48
dr. zelenetz highlights studies from the 2012 ash meeting
-
2:00
dr. zelenetz discusses the chemotherapy delivery process
-
1:32
dr. zelenetz on zanubrutinib research in mcl
-
1:54
dr. zelenetz on the role of biosimilars
-
1:21
the future of lymphoma treatment – combining new therapies with molecular diagnosis
-
2:18
dr. zelenetz discusses the winter hematology meeting
-
4:10
stephen m. ansell, md, phd: nivolumab moves to hematology